Millions of people take seizure medications every day for conditions that have nothing to do with epilepsy, and in many cases, that is exactly what their doctor intended. Drugs originally developed to prevent seizures have become standard treatments for nerve pain, bipolar disorder, migraines, anxiety, and fibromyalgia. But the fact that a doctor prescribed the medication does not make it benign. These drugs alter brain chemistry in broad ways, and the side effects you face are the same whether you have seizures or not. The picture gets more complicated if you are taking someone else’s medication, experimenting recreationally, or simply wondering whether that leftover prescription in the medicine cabinet could hurt you.
Why Seizure Drugs Are Prescribed to People Without Seizures
Anti-seizure medications calm overactive nerve signaling. That same mechanism turns out to be useful in a surprisingly wide range of conditions where nerves are misfiring or mood circuits are unstable. Gabapentin and pregabalin are among the most commonly prescribed drugs in the world, and in many countries, pain and anxiety are the primary reasons they are used, not epilepsy. Evidence supports pregabalin and gabapentin for painful diabetic neuropathy and postherpetic neuralgia, with pregabalin also showing benefit in central nerve pain and fibromyalgia.1PubMed Central. Antiepileptic drugs for neuropathic pain and fibromyalgia ‐ an overview of Cochrane reviews Carbamazepine, valproate, and lamotrigine are used as mood stabilizers in bipolar disorder. Topiramate and valproate are prescribed for migraine prevention. Lamotrigine has antidepressant properties, while gabapentin, pregabalin, and tiagabine show anxiolytic effects.2PubMed Central. Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain
The evidence quality varies dramatically across these uses. For gabapentin and pregabalin in nerve pain, the data from randomized trials is reasonably solid. For some psychiatric uses, published evidence from large, rigorous trials is thin. This matters because it means a person taking a seizure drug for, say, generalized anxiety may be absorbing all the side effects of the drug while receiving uncertain benefit. The risk-benefit math still applies, but the “benefit” side of the equation is sometimes shakier than patients realize.
Cognitive Side Effects, Especially With Topiramate
The side effect that tends to surprise people most is cognitive blunting. These drugs are designed to quiet neural activity, and some of them quiet it in areas of the brain responsible for memory, word-finding, and processing speed. Topiramate is the standout offender. In a study comparing topiramate, gabapentin, and placebo in healthy volunteers with no neurological conditions, topiramate caused large performance drops on tests of memory, verbal fluency, and processing speed. Several measures averaged more than two standard deviations of negative change, which in practical terms means noticeably worse performance on tasks like recalling a story or generating words that start with a given letter. Gabapentin, by contrast, affected only one of 24 measured cognitive variables.3PubMed. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers
Working memory takes a particular hit. In a controlled study of healthy adults given topiramate, accuracy on a working memory task dropped from about 72% to 63% on the hardest trials, and from roughly 96% to 88% even on the easiest ones.4PubMed Central. Severity of Topiramate-Related Working Memory Impairment is Modulated by Plasma Concentration and Working Memory Capacity People sometimes describe the feeling as being in a fog or struggling to think of words they know perfectly well. This has earned topiramate the nickname “dopamax” among patients. The cognitive effects are dose-dependent, so they tend to be worse at higher doses, but they can occur even at the moderate doses used for migraine prevention.5PubMed Central. Topiramate and cognitive impairment: evidence and clinical implications
For someone with epilepsy, trading some mental sharpness for seizure control may be a clear bargain. For someone taking topiramate to prevent migraines or lose weight, the cognitive cost deserves a harder look.
Weight Changes Cut Both Ways
Different seizure medications push body weight in different directions, and the effects can be substantial. Valproate causes weight gain in up to half of the people who take it, often noticeable within two to three months. Levetiracetam and valproate were both associated with significant weight gain in a large observational study of over 1,400 patients.6PubMed. Weight change associated with antiepileptic drugs On the other side, topiramate was linked to significant weight loss, averaging a couple of kilograms. Lamotrigine and carbamazepine appeared roughly weight-neutral.7PubMed. Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder
This is part of why topiramate has sometimes been prescribed or sought out specifically for weight loss, and why valproate can be a frustrating choice for patients already concerned about weight. If you are taking one of these drugs for a non-seizure condition and notice unexplained weight changes, the medication is a likely suspect.
Balance, Sedation, and Fall Risk
Many anti-seizure drugs cause drowsiness, dizziness, and impaired coordination. These are among the most commonly reported side effects across the class, and they matter a lot in real life, especially for older adults. A systematic review found a clear association between anti-seizure drug use and an increased risk of falls and recurrent falls in older people.8PubMed. Use of antiepileptic drugs and risk of falls in old age: A systematic review This is relevant for people without epilepsy because many of the conditions these drugs treat, like nerve pain and mood disorders, are common in older adults, meaning millions of older people are taking drugs that increase their chances of a fall.
Balance and reaction time in people on anti-seizure drugs are measurably impaired compared to controls, and these deficits do not bounce back quickly after stopping the medication. The impairment may reflect lasting effects on the vestibular system or cerebellum.9PubMed. Balance and reaction time do not rapidly improve off antiseizure drugs The good news is that not every drug in the class is equally problematic. A randomized, placebo-controlled trial of levetiracetam in healthy older adults found no differences between the drug and placebo on roughly 90% of the measures tested, including balance.10PubMed. A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults So the risk depends heavily on which drug you are taking.
Behavioral and Mood Changes
Some seizure medications alter mood and behavior in ways that can be alarming. Levetiracetam is well known for causing irritability and, in some cases, outright aggression. A preclinical study comparing levetiracetam with a newer relative, brivaracetam, found that animals receiving levetiracetam (even those without seizure conditions) were twice as fast to attack at first encounter, showed five times more aggressive behaviors, and significantly less social behavior than controls.11Epilepsy & Behavior. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model Patients and family members sometimes describe a personality change, with short temper or emotional flatness appearing within weeks of starting the drug.
These behavioral effects matter even more when the person taking the drug does not have epilepsy, because there is no seizure-control benefit to offset them. If you or someone close to you starts acting differently after beginning one of these medications, the drug should be on the list of possible explanations.
Drug Interactions That Can Catch You Off Guard
Several seizure drugs are powerful liver enzyme inducers or inhibitors, which means they speed up or slow down the breakdown of other medications in your body. This is not an abstract concern. Carbamazepine strongly induces the liver enzyme CYP3A4, which is involved in metabolizing a huge number of common drugs. Taking carbamazepine can reduce the effectiveness of oral contraceptives, blood thinners, antidepressants, antipsychotics, immunosuppressants, and certain cardiovascular medications.12PubMed. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. A woman taking carbamazepine for nerve pain who also relies on birth control pills could find herself with an unplanned pregnancy because the seizure drug chewed through her contraceptive before it could do its job.
Phenytoin and phenobarbital are similarly potent inducers, while valproate goes the other direction, inhibiting enzymes and potentially causing other drugs to build up to toxic levels. Gabapentin, tiagabine, and vigabatrin are comparatively safe on this front, as they neither induce nor inhibit drug metabolism significantly.13PubMed. A mechanistic approach to antiepileptic drug interactions If you are prescribed a seizure drug for any reason, your pharmacist should be checking for interactions, but the more medications you take, the more likely something slips through the cracks.
Serious Skin Reactions
Lamotrigine, one of the most commonly prescribed seizure drugs for both epilepsy and bipolar disorder, carries a rare but potentially life-threatening risk of Stevens-Johnson Syndrome, a severe immune reaction that causes the skin to blister and peel. Antiepileptic drugs as a class are among the most common medication-related causes of this condition, and lamotrigine is the antiepileptic most frequently associated with it.14PubMed Central. Lamotrigine and Stevens-Johnson Syndrome Prevention
The actual incidence is low. A systematic review of 122 randomized controlled trials covering nearly 19,000 patients on lamotrigine found that about 8% experienced some kind of skin reaction, but the rate of Stevens-Johnson Syndrome or toxic epidermal necrolysis was 0.04%.15PubMed Central. Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials That is rare enough that most people taking lamotrigine will never encounter it, but serious enough that it demands attention. Cases typically develop within the first few weeks of use, especially if the dose is increased too quickly.16PubMed Central. Stevens Johnson Syndrome associated with Lamotrigine Any new rash while starting lamotrigine, regardless of whether you take it for seizures or mood, should be evaluated immediately. This is one reason lamotrigine prescriptions typically follow a slow dose-escalation schedule.
Genetic factors play into who is susceptible. Specific immune-system gene variants, particularly HLA-B*15:02 and HLA-A*31:01, are strong predictors of severe skin reactions to carbamazepine, oxcarbazepine, and phenytoin. These variants are more common in certain ethnic populations, and pre-treatment genetic screening is recommended in some guidelines.17PubMed. Pharmacogenomics of anti-seizure medications in epilepsy: a systematic review of genetic predictors of response and tolerance
Bone Health Over Months and Years
Long-term use of certain seizure drugs weakens bones, and this is one of the effects that both patients and doctors tend to underappreciate. Enzyme-inducing drugs like phenobarbital, carbamazepine, and phenytoin are the primary culprits. They accelerate vitamin D metabolism in the liver, which reduces calcium absorption and gradually erodes bone density.18PubMed Central. Antiepileptics and bone health But newer anti-seizure drugs and valproate are not off the hook. Research shows significant bone density reductions across a broader range of these medications, with osteoporosis affecting an estimated 11% to 31% of patients with long-term exposure and a two to six times increased risk of fractures compared to the general population.19PubMed. Impaired bone health as a co-morbidity of epilepsy
If you are taking one of these drugs for a condition like nerve pain or mood stabilization, which may require years of treatment, the bone health question is worth raising with your doctor. Bone density testing and vitamin D supplementation are reasonable steps for anyone on long-term therapy.
The Abuse and Dependence Problem With Gabapentinoids
Gabapentin and pregabalin occupy an unusual space. They are widely prescribed, generally considered safe by prescribers, and for most people, they are not particularly addictive. But for a subset of users, particularly those with a history of opioid use, these drugs produce a euphoric high, and the abuse potential has become a growing clinical concern. In the general population, about 1.6% of gabapentinoid users show signs of abuse. Among people with opioid use disorders, that rate climbs dramatically, ranging from 3% to 68% depending on the study and population.20PubMed. Abuse and Misuse of Pregabalin and Gabapentin
A large French population-based study found that misuse was more common with pregabalin than gabapentin: roughly 13% of new pregabalin users showed patterns consistent with misuse, compared to about 7% for gabapentin. Younger age, having multiple prescribers, and a history of depression or substance use were all associated with higher risk. Among those who misused the drugs, about 10-12% went on to develop a primary addiction.21PubMed Central. Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France Recreational use of pregabalin has been observed among adolescents, often in combination with opioids or alcohol, and withdrawal symptoms can follow abrupt discontinuation even at recommended doses.22Adverse Drug Reaction Bulletin. A review of the addictive potential of pregabalin and gabapentin Several countries have responded by reclassifying pregabalin as a controlled substance.
What Happens If You Stop Suddenly
Stopping a seizure medication abruptly carries real risks, even if you do not have epilepsy. The brain adapts to the presence of these drugs over time, and yanking them away can destabilize neural circuits. In a study of patients with non-epileptic seizures (psychogenic events, not electrical seizures) who were being withdrawn from anti-seizure drugs they did not need, five patients stopped abruptly, and three of them developed a new type of attack: actual epileptic seizures, specifically complex partial seizures, that had not been present before.23PubMed Central. The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures
This is a striking finding. People who had been taking seizure drugs despite not having a seizure disorder developed actual seizures when the drugs were removed too quickly. The mechanism involves the brain’s adaptation: the neurons have adjusted to a drug that suppresses excitability, and when that suppression vanishes overnight, the brain can overshoot into hyperexcitability. Benzodiazepines and barbiturates carry the most dramatic withdrawal risks, but even drugs like gabapentin and pregabalin can produce withdrawal symptoms including insomnia, anxiety, and nausea. The standard advice for any seizure medication is to taper gradually under medical supervision.
Pregnancy Risks Apply Regardless of the Indication
One of the most consequential findings in this space is that the reproductive risks of seizure medications do not depend on why you are taking them. A study examining pregnancy outcomes in women taking anti-seizure drugs for non-epilepsy indications found a similar risk of congenital malformations as in women taking the same drugs for epilepsy.24PubMed. Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications Valproate carries the highest risk and is associated with neural tube defects and developmental delays. The risk is a property of the drug, not the disease. A woman taking valproate for migraines faces the same teratogenic exposure as a woman taking it for epilepsy.
This matters because the decision calculus is different. For someone with severe epilepsy, the risks of uncontrolled seizures during pregnancy can be worse than the medication risks, making continuation a defensible choice. For someone taking the same drug for migraines or mood stabilization, alternative treatments with lower fetal risk often exist, making the conversation about switching more urgent.
What an Overdose Looks Like
Taking a large quantity of seizure medication, whether accidentally or intentionally, produces a recognizable set of symptoms. Common signs of anti-seizure drug toxicity include altered consciousness, sluggishness, unsteady gait, and involuntary eye movements. Paradoxically, some seizure medications can actually cause seizures in overdose, particularly tiagabine, lamotrigine, and oxcarbazepine.25PubMed Central. Clinical outcomes in newer anticonvulsant overdose: a poison center observational study Drug-specific dangers include cardiac rhythm problems with carbamazepine, dangerous drops in blood sodium with oxcarbazepine, and a condition called hyperammonemic encephalopathy (essentially brain swelling from ammonia buildup) with valproate. Phenobarbital overdose can suppress breathing and drop blood pressure to dangerous levels.26PubMed Central. Antiepileptic Overdose
Children are especially vulnerable to accidental ingestion. A review of lamotrigine overdose cases found that among pediatric exposures, seizures occurred in the majority of children under three and a half years old, and most of those children did not have an underlying seizure disorder. Two adult fatalities were reported in the same review, at ingested doses of 4 grams and 7.5 grams.27PubMed. Acute lamotrigine overdose: a systematic review of published adult and pediatric cases If you keep these medications in the house and do not have epilepsy, they should be stored as carefully as any other potentially dangerous prescription.
The Misdiagnosis Problem
There is a surprisingly common clinical scenario in which people without seizures end up taking seizure medications, and not because of an off-label prescription. Psychogenic non-epileptic seizures (events that look like seizures but are not caused by abnormal electrical activity in the brain) are frequently misdiagnosed as epilepsy. These patients are then placed on anti-seizure drugs that cannot help them and that expose them to all the side effects described above. Worse, when these episodes are misidentified as status epilepticus (a prolonged seizure emergency), patients may receive aggressive intravenous treatments. In two major emergency treatment trials, roughly a quarter of patients with psychogenic non-epileptic events who were treated as if they were having real seizures experienced adverse effects including respiratory depression requiring a breathing tube. About 15-31% of these patients required admission to the intensive care unit.28PubMed Central. Misdiagnosis of prolonged psychogenic non-epileptic seizures as status epilepticus: epidemiology and associated risks
This is one of the more sobering illustrations of what can happen when seizure drugs are given to people who do not need them. The drugs themselves caused harm in patients whose condition, by definition, could not respond to them. Correct diagnosis typically requires video-EEG monitoring in a specialized center, and advocacy groups have pushed for faster referrals to prevent unnecessary drug exposure.
Monitoring That Often Gets Skipped
Certain seizure medications require regular blood work to catch organ damage early. Valproate can cause liver toxicity, and carbamazepine can suppress blood cell production. Guidelines call for baseline and follow-up lab monitoring, but adherence to these guidelines is spotty. A study in a Nigerian epilepsy clinic found that pretreatment liver monitoring was done in only about a third of patients starting valproate, and follow-up monitoring dropped to 19%. For carbamazepine, baseline blood counts were checked in about 61% of patients, but follow-up monitoring fell to under 4%.29PubMed Central. Infrequent Monitoring of the Effects of Valproate and Carbamazepine Therapy in Patients With Epilepsy in Nigeria While this study was from a single setting, undermonitoring is a recognized problem internationally. If you are taking one of these drugs for any reason and your doctor has not ordered lab work, it is worth asking about it.
The monitoring gap tends to be wider for off-label uses, partly because the prescribing physician may be a psychiatrist, pain specialist, or primary care doctor who is less accustomed to the specific monitoring protocols that neurologists follow for these drugs. The side effect profile does not change depending on the specialty of the prescriber, though. The drug does not know why you are taking it.